The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial

The study was approved by the Ethics Committee of Shanghai Tongji Hospital (2020-KYSB-160, 2021-086) and registered in the Chinese Clinical Trial Registry (ChiCTR2000037429).

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-01-13
DOI
https://doi.org/10.1186/s12916-025-04613-x
Primary Topic
Respiratory and Cough-Related Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial

Cuiqin Shi, Yaxing Zhou, Tongyangzi Zhang, Heng Wu et al.
BMC Medicine
Respiratory and Cough-Related Research
article

The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial

Cuiqin Shi, Yaxing Zhou, Tongyangzi Zhang, Heng Wu, Xianghuai Xu, Li Yu, Wanzhen Li, Shengyuan Wang
article en

Abstract

The study was approved by the Ethics Committee of Shanghai Tongji Hospital (2020-KYSB-160, 2021-086) and registered in the Chinese Clinical Trial Registry (ChiCTR2000037429).

BMC MedicineVol. 24(1)
Tongji University (CN), Tongji Hospital (CN)
Good health and well-being
Openalex Percentile: Top 90%
Respiratory and Cough-Related Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.